The invention relates to the use of 3-methyl-6-(1-methylethenyl)cyclohex-3-ene-1,2-diol and isomers and derivatives thereof as an agent for treating Parkinsons disease, and can be used in the field of medicine. The agent has high activity and low toxicity and can be produced from the accessible naturally occurring compound α-pinene.